One of the Nation’s Most Affordable LegitScript-Certified GLP-1 Programs, Starting at $99/mo

CoraDoc offers a streamlined telehealth experience designed to make getting started simple and convenient.

1. Complete a Medical Intake: Fill out your online health history form.

2. Connect with a Licensed Healthcare Provider: A licensed provider reviews your information and determines whether treatment is appropriate based on individual medical review.

3. Prescription and Fulfillment: If prescribed, your medication is fulfilled through CoraDoc’s pharmacy partners and shipped to your address.

CoraDoc provides a structured weight management program with ongoing provider support and convenient access to care. Individual results vary. Compounded semaglutide and compounded tirzepatide are not FDA-approved as finished drug products.

Semaglutide programs are available starting at $99 per month as part of a 6-month program, based on your provider-approved treatment plan.

Our tirzepatide programs generally start at $149 per month, which includes your online medical appointment, provider oversight, medication fulfillment, and shipping. There are no hidden fees and no long-term contracts.

CoraDoc’s Triple Free Promise means your program includes:
• Free online provider visit
• Free shipping
• Free supplies, when applicable

We focus on offering clear, straightforward pricing so patients understand exactly what’s included before starting care. Final pricing and program details may vary depending on the treatment plan prescribed by a licensed healthcare provider.

Since CoraDoc does not operate on a subscription model, there's nothing to cancel once your order is placed. However, if you need to request a refund or stop fulfillment, please contact us immediately at careteam@coradoc.com or call us at 1-855-983-5336. Refunds may be issued only if the medication has not yet been prepared or shipped. Once your prescription is in progress or has been shipped from the pharmacy, we are unable to offer refunds due to safety regulations.

CoraDoc is LegitScript certified and committed to compliance, safety, and transparency. All medications are prepared by State Board of Pharmacy–licensed sterile compounding pharmacies or FDA-registered 503(b) outsourcing facilities. Our partner pharmacies are licensed to dispense in applicable states and follow strict quality and safety standards. Treatment is prescribed and monitored by licensed healthcare providers, and individual results may vary.

In general, most clients typically receive their medication within 3-5 business days from their initial consultation with their provider.

Please refer to the instructional video below for general guidance on administering a subcutaneous injection. Always follow the dosing and injection instructions provided by your licensed healthcare provider. If you have questions or concerns, contact your provider before administering your medication.

Common injection sites include the abdomen, thigh, or upper arm. Clean the area with an alcohol swab, draw the prescribed dose as instructed, administer the injection as directed by your provider, and dispose of used needles in a sharps container.

For a visual demonstration, watch the instructional video linked here. How to inject Semaglutide or Tirzepatide for best results!

For GLP-1 weight loss programs, patients must be at least 18 years old and no older than 75.

GLP-1 prescription weight loss medications can be effective in managing weight and improving metabolic health for many individuals. However, certain groups may face risks or contraindications when using these medications. It's crucial to consult a healthcare provider before starting any new medication, including GLP-1 receptor agonists. Below are some groups who should generally avoid GLP-1 prescription weight loss medications:

1. Pregnant and Breastfeeding Women
The safety of GLP-1 receptor agonists during pregnancy and breastfeeding is not well-established. Women who are pregnant or breastfeeding should avoid these medications unless specifically advised by their healthcare provider.

2. Individuals with a History of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia Syndrome Type 2 (MEN2)
Some GLP-1 receptor agonists have been linked to an increased risk of thyroid C-cell tumors in animal studies. People with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) should generally avoid these medications.

3. People with Severe Gastrointestinal Disorders
GLP-1 receptor agonists can cause gastrointestinal side effects, including nausea, vomiting, and diarrhea. Those with severe gastrointestinal disorders may be more susceptible to these side effects and should use these medications with caution.

4. Individuals with Type 1 Diabetes
GLP-1 receptor agonists are primarily designed for individuals with type 2 diabetes or for weight management. They are not suitable for people with type 1 diabetes, as their mechanism of action targets insulin production and glucose regulation related to type 2 diabetes.

5. Patients with a History of Pancreatitis
Patients with a history of pancreatitis should use GLP-1 receptor agonists cautiously, as these medications can potentially increase the risk of developing pancreatitis.

6. Individuals with Renal Impairment
Certain GLP-1 receptor agonists may require dosage adjustments for individuals with moderate to severe renal impairment. It's essential to assess kidney function with your healthcare provider before using these medications.

7. Individuals with Severe Liver Impairment
People with severe liver impairment may require dose adjustments or should avoid GLP-1 receptor agonists, as these medications can affect liver function.

8. Those with Allergies or Sensitivities
Individuals with known allergies or sensitivities to GLP-1 receptor agonists or any of their components should not use these medications.

Consult with Your Healthcare Provider
It is essential to have an open discussion with your healthcare provider regarding your medical history, current health status, and any potential risks before starting GLP-1 prescription weight loss medications. Your healthcare provider will evaluate your situation to determine if these medications are a safe and effective choice for you.

At CoraDoc, we do not accept public or private health insurance, cost-sharing arrangements, or similar payment methods. Clients are responsible for paying the full cost of our services. However, we provide invoices that you can submit to your insurance company for potential reimbursement. If you encounter difficulties obtaining insurance coverage for weight loss services, consider the following options:

Appeal to your insurance company to review and reconsider your claim.
Request that your employer assist with covering the cost of weight loss medications.
Explore alternative health insurance plans that may offer better coverage for weight loss treatments.